Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
Public ClinicalTrials.gov record NCT01489059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I Dose Escalation Study of BMS-982470 (Recombinant Interleukin 21, rIL-21) in Combination With Ipilimumab in Subjects With Unresectable Stage III or Stage IV Melanoma
Study identification
- NCT ID
- NCT01489059
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- BMS-982470 (recombinant interleukin-21) Biological
- Ipilimumab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011
- Primary completion
- May 31, 2014
- Completion
- May 31, 2014
- Last update posted
- Aug 28, 2014
2011 – 2014
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oncology Research Associates, Pllc D/B/A | Scottsdale | Arizona | 85258 | — |
| Ucla Hematology/Oncology. | Los Angeles | California | 90095 | — |
| H. Lee Moffitt Cancer Center & Research Inst, Inc | Tampa | Florida | 33612 | — |
| Indiana University Health Melvin And Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| University Of Louisville Medical Center, Inc., Dba | Louisville | Kentucky | 40202 | — |
| Portland Providence Medical Center | Portland | Oregon | 97213 | — |
| Md Anderson Can Cnt | Houston | Texas | 77030 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01489059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2014 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01489059 live on ClinicalTrials.gov.